SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:DiVA.org:liu-136048"
 

Search: onr:"swepub:oai:DiVA.org:liu-136048" > RUNX1 cooperates wi...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist
  • Behrens, KiraLeibniz Institute Expt Virol, Germany; Walter and Eliza Hall Institute Medical Research, Australia (author)

RUNX1 cooperates with FLT3-ITD to induce leukemia

  • Article/chapterEnglish2017

Publisher, publication year, extent ...

  • 2017-02-17
  • ROCKEFELLER UNIV PRESS,2017
  • electronicrdacarrier

Numbers

  • LIBRIS-ID:oai:DiVA.org:liu-136048
  • https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-136048URI
  • https://doi.org/10.1084/jem.20160927DOI

Supplementary language notes

  • Language:English
  • Summary in:English

Part of subdatabase

Classification

  • Subject category:ref swepub-contenttype
  • Subject category:art swepub-publicationtype

Notes

  • Funding Agencies|Deutsche Krebshilfe Foundation; Bundesministerium fur Gesundheit; Freie und Hansestadt Hamburg
  • Acute myeloid leukemia (AML) is induced by the cooperative action of deregulated genes that perturb self-renewal, proliferation, and differentiation. Internal tandem duplications (ITDs) in the FLT3 receptor tyrosine kinase are common mutations in AML, confer poor prognosis, and stimulate myeloproliferation. AML patient samples with FLT3-ITD express high levels of RUNX1, a transcription factor with known tumor-suppressor function. In this study, to understand this paradox, we investigated the impact of RUNX1 and FLT3-ITD coexpression. FLT3-ITD directly impacts on RUNX1 activity, whereby up-regulated and phosphorylated RUNX1 cooperates with FLT3-ITD to induce AML. Inactivating RUNX1 in tumors releases the differentiation block and down-regulates genes controlling ribosome biogenesis. We identified Hhex as a direct target of RUNX1 and FLT3-ITD stimulation and confirmed high HHEX expression in FLT3-ITD AMLs. HHEX could replace RUNX1 in cooperating with FLT3-ITD to induce AML. These results establish and elucidate the unanticipated oncogenic function of RUNX1 in AML. We predict that blocking RUNX1 activity will greatly enhance current therapeutic approaches using FLT3 inhibitors.

Subject headings and genre

Added entries (persons, corporate bodies, meetings, titles ...)

  • Maul, KatrinLeibniz Institute Expt Virol, Germany (author)
  • Tekin, NilguenLeibniz Institute Expt Virol, Germany; Leibniz Institute Expt Virol, Germany (author)
  • Kriebitzsch, NeeleLeibniz Institute Expt Virol, Germany (author)
  • Indenbirken, DanielaLeibniz Institute Expt Virol, Germany (author)
  • Prassolov, VladimirEngelhardt Institute Molecular Biol, Russia (author)
  • Mueller, UrsulaLeibniz Institute Expt Virol, Germany (author)
  • Serve, HubertGoethe University of Frankfurt, Germany (author)
  • Cammenga, JörgLinköpings universitet,Avdelningen för Kirurgi, Ortopedi och Onkologi,Medicinska fakulteten,Region Östergötland, Hematologiska kliniken US(Swepub:liu)jorca02 (author)
  • Stocking, CarolLeibniz Institute Expt Virol, Germany (author)
  • Leibniz Institute Expt Virol, Germany; Walter and Eliza Hall Institute Medical Research, AustraliaLeibniz Institute Expt Virol, Germany (creator_code:org_t)

Related titles

  • In:Journal of Experimental Medicine: ROCKEFELLER UNIV PRESS214:3, s. 737-7520022-10071540-9538

Internet link

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view